
Lakia J. Jackson-tongue
Examiner (ID: 2679, Phone: (571)272-2921 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 887 |
| Issued Applications | 525 |
| Pending Applications | 105 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10201594
[patent_doc_number] => 20150086583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'MUCIN-ASSOCIATED SURFACE PROTEIN AS VACCINE AGAINST CHAGAS DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/494812
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3166
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14494812
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/494812 | Mucin-associated surface protein as vaccine against Chagas disease | Sep 23, 2014 | Issued |
Array
(
[id] => 13116443
[patent_doc_number] => 10076557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Botulinum toxin therapy for skin disorders
[patent_app_type] => utility
[patent_app_number] => 14/493756
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14008
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493756
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/493756 | Botulinum toxin therapy for skin disorders | Sep 22, 2014 | Issued |
Array
(
[id] => 9857844
[patent_doc_number] => 20150037862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'Over-Production of Secondary Metabolites by Over-Expression of the VEA Gene'
[patent_app_type] => utility
[patent_app_number] => 14/485985
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24184
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485985
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/485985 | Over-production of secondary metabolites by over-expression of the VEA gene | Sep 14, 2014 | Issued |
Array
(
[id] => 10967004
[patent_doc_number] => 20140370036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'COMPOSITIONS OF, AND METHODS FOR, ALPHA-1 ANTITRYPSIN FcFUSION MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/465733
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23431
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14465733
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/465733 | Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules | Aug 20, 2014 | Issued |
Array
(
[id] => 10938926
[patent_doc_number] => 20140341947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS'
[patent_app_type] => utility
[patent_app_number] => 14/447694
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50103
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14447694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/447694 | Immunogenic compositions comprising Lawsonia intracellularis | Jul 30, 2014 | Issued |
Array
(
[id] => 9785738
[patent_doc_number] => 20140302558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'MODIFIED BORDETELLA PERTUSSIS STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/309807
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10597
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/309807 | Modified Bordetella pertussis strains | Jun 18, 2014 | Issued |
Array
(
[id] => 10474863
[patent_doc_number] => 20150359880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'DUAL ADJUVANT VACCINE COMPOSITIONS, PREPARATION AND USES'
[patent_app_type] => utility
[patent_app_number] => 14/305329
[patent_app_country] => US
[patent_app_date] => 2014-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9686
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14305329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/305329 | DUAL ADJUVANT VACCINE COMPOSITIONS, PREPARATION AND USES | Jun 15, 2014 | Abandoned |
Array
(
[id] => 18050700
[patent_doc_number] => 11524067
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Methods of vaccine administration
[patent_app_type] => utility
[patent_app_number] => 14/282702
[patent_app_country] => US
[patent_app_date] => 2014-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7409
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282702
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/282702 | Methods of vaccine administration | May 19, 2014 | Issued |
Array
(
[id] => 10006860
[patent_doc_number] => 09050358
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Compositions and methods for probiotic recolonization therapies'
[patent_app_type] => utility
[patent_app_number] => 14/270034
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6060
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/270034 | Compositions and methods for probiotic recolonization therapies | May 4, 2014 | Issued |
Array
(
[id] => 9685351
[patent_doc_number] => 20140242115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'INACTIVATING PATHOGENS WITH OXIDIZING AGENTS FOR VACCINE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 14/269708
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14525
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/269708 | Inactivating pathogens with oxidizing agents for vaccine production | May 4, 2014 | Issued |
Array
(
[id] => 10656177
[patent_doc_number] => 20160002321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'MONOCLONAL ANTIBODIES TO ANTHRAX PROTECTIVE ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 14/268641
[patent_app_country] => US
[patent_app_date] => 2014-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10626
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14268641
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/268641 | Monoclonal antibodies to anthrax protective antigen | May 1, 2014 | Issued |
Array
(
[id] => 11204060
[patent_doc_number] => 09433672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'Compositions and methods for activating innate and allergic immunity'
[patent_app_type] => utility
[patent_app_number] => 14/263390
[patent_app_country] => US
[patent_app_date] => 2014-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 28594
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14263390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/263390 | Compositions and methods for activating innate and allergic immunity | Apr 27, 2014 | Issued |
| 14/239772 | VACCINE FOR PROTECTION AGAINST ETEC INDUCED DIARRHEA COMPRISING DMLT | Apr 22, 2014 | Abandoned |
Array
(
[id] => 10728346
[patent_doc_number] => 20160074496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'CLOSTRIDIUM DIFFICILE VACCINE AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/786415
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10316
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/786415 | Clostridium difficile vaccine and methods of use | Apr 21, 2014 | Issued |
Array
(
[id] => 9756271
[patent_doc_number] => 20140286972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'HYPOALLERGENIC CHIMERIC PROTEINS BELONGING TO THE LIPID TRANSFER FAMILY OF PARIETARIA JUDAICA FOR USE IN THE TREATMENT OF ALLERGIES'
[patent_app_type] => utility
[patent_app_number] => 14/198293
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12170
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198293
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/198293 | Hypoallergenic chimeric proteins belonging to the lipid transfer family of Parietaria judaica for use in the treatment of allergies | Mar 4, 2014 | Issued |
Array
(
[id] => 9546004
[patent_doc_number] => 20140170652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'TARGET CAPTURE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/107315
[patent_app_country] => US
[patent_app_date] => 2013-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 20256
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14107315
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/107315 | Target capture system | Dec 15, 2013 | Issued |
Array
(
[id] => 9408087
[patent_doc_number] => 20140099339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 14/101995
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8011
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14101995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/101995 | VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE | Dec 9, 2013 | Abandoned |
Array
(
[id] => 11198369
[patent_doc_number] => 09428572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Human binding molecules having killing activity against enterococci'
[patent_app_type] => utility
[patent_app_number] => 14/101584
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28187
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14101584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/101584 | Human binding molecules having killing activity against enterococci | Dec 9, 2013 | Issued |
Array
(
[id] => 9449444
[patent_doc_number] => 20140120614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/080598
[patent_app_country] => US
[patent_app_date] => 2013-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 24164
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/080598 | Antibodies against clostridium difficile toxins and uses thereof | Nov 13, 2013 | Issued |
Array
(
[id] => 9448909
[patent_doc_number] => 20140120077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'Compositions and Methods for Safe Treatment of Rhinitis'
[patent_app_type] => utility
[patent_app_number] => 14/065379
[patent_app_country] => US
[patent_app_date] => 2013-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17819
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065379
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/065379 | Compositions and Methods for Safe Treatment of Rhinitis | Oct 27, 2013 | Abandoned |